The DOI matches its Crossref record; 183 of the 183 references it cites were found in a registry or an index.
The Role of Hypoxia in Glioblastoma Invasion
Open accessAbstract
Glioblastoma multiforme (GBM), a grade IV astrocytoma, is the most common and deadly type of primary malignant brain tumor, with a patient’s median survival rate ranging from 15 to 17 months. The current treatment for GBM involves tumor resection surgery based on MRI image analysis, followed by radiotherapy and treatment with temozolomide. However, the gradual development of tumor resistance to temozolomide is frequent in GBM patients leading to subsequent tumor regrowth/relapse. For this reason, the development of more effective therapeutic approaches for GBM is of critical importance. Low tumor oxygenation, also known as hypoxia, constitutes a major concern for GBM patients, since it promotes cancer cell spreading (invasion) into the healthy brain tissue in order to evade this adverse microenvironment. Tumor invasion not only constitutes a major obstacle to surgery, radiotherapy, and chemotherapy, but it is also the main cause of death in GBM patients. Understanding how hypoxia triggers the GBM cells to become invasive is paramount to developing novel and more effective therapies against this devastating disease. In this review, we will present a comprehensive examination of the available literature focused on investigating how GBM hypoxia triggers an invasive cancer cell phenotype and the role of these invasive proteins in GBM progression.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Hill, R., Madureira, P. A., Ferreira, B. I., Baptista, I., Machado, S., Colaço, L., dos Santos, M., Liu, N., Dopazo, A., Ugurel, S., et al. (2017) · Nature Communications · doi:10.1038/ncomms14687 · Cited by 69
Self-citationRetractedRadiotherapy Plus Concomitant and Adjuvant Temozolomide for Glioblastoma
Stupp, R., Mason, W. P., van den Bent, M. J., Weller, M., Fisher, B., Taphoorn, M. J. B., Belanger, K., Brandes, A. A., Marosi, C., Bogdahn, U., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043330 · Cited by 21,807
The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary
Louis, D. N., Perry, A., Reifenberger, G., von Deimling, A., Figarella-Branger, D., Cavenee, W. K., Ohgaki, H., Wiestler, O. D., Kleihues, P., & Ellison, D. W. (2016) · Acta Neuropathologica · doi:10.1007/s00401-016-1545-1 · Cited by 15,657
Comprehensive genomic characterization defines human glioblastoma genes and core pathways
The Cancer Genome Atlas Research Network (2008) · Nature · doi:10.1038/nature07385 · Cited by 7,735
Stupp, R., Hegi, M. E., Mason, W. P., van den Bent, M. J., Taphoorn, M. J., Janzer, R. C., Ludwin, S. K., Allgeier, A., Fisher, B., Belanger, K., et al. (2009) · The Lancet Oncology · doi:10.1016/s1470-2045(09)70025-7 · Cited by 7,668
Verhaak, R. G. W., Hoadley, K. A., Purdom, E., Wang, V., Qi, Y., Wilkerson, M. D., Miller, C. R., Ding, L., Golub, T., Mesirov, J. P., et al. (2010) · Cancer Cell · doi:10.1016/j.ccr.2009.12.020 · Cited by 7,575
MGMT Gene Silencing and Benefit from Temozolomide in Glioblastoma
Hegi, M. E., Diserens, A.-C., Gorlia, T., Hamou, M.-F., de Tribolet, N., Weller, M., Kros, J. M., Hainfellner, J. A., Mason, W., Mariani, L., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043331 · Cited by 7,405
Molecular Mechanisms of Stress-Responsive Changes in Collagen and Elastin Networks in Skin
Aziz, J., Shezali, H., Radzi, Z., Yahya, N. A., Abu Kassim, N. H., Czernuszka, J., & Rahman, M. T. (2016) · Skin Pharmacology and Physiology · doi:10.1159/000447017 · Cited by 7,323
The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis
Maxwell, P. H., Wiesener, M. S., Chang, G.-W., Clifford, S. C., Vaux, E. C., Cockman, M. E., Wykoff, C. C., Pugh, C. W., Maher, E. R., & Ratcliffe, P. J. (1999) · Nature · doi:10.1038/20459 · Cited by 5,180
The Somatic Genomic Landscape of Glioblastoma
Brennan, C. W., Verhaak, R. G. W., McKenna, A., Campos, B., Noushmehr, H., Salama, S. R., Zheng, S., Chakravarty, D., Sanborn, J. Z., Berman, S. H., et al. (2013) · Cell · doi:10.1016/j.cell.2013.09.034 · Cited by 5,016
Targeting Hypoxia-Inducible Factors for the Treatment of Anemia in Chronic Kidney Disease Patients
Locatelli, F., Fishbane, S., Block, G. A., & Macdougall, I. C. (2017) · American Journal of Nephrology · doi:10.1159/000455166 · Cited by 4,813
Matrix Crosslinking Forces Tumor Progression by Enhancing Integrin Signaling
Levental, K. R., Yu, H., Kass, L., Lakins, J. N., Egeblad, M., Erler, J. T., Fong, S. F. T., Csiszar, K., Giaccia, A., Weninger, W., et al. (2009) · Cell · doi:10.1016/j.cell.2009.10.027 · Cited by 4,101
Immunotherapy of Diffuse Gliomas: Biological Background, Current Status and Future Developments
Grauer, O. M., Wesseling, P., & Adema, G. J. (2009) · Brain Pathology · doi:10.1111/j.1750-3639.2009.00315.x · Cited by 4,007
Phillips, H. S., Kharbanda, S., Chen, R., Forrest, W. F., Soriano, R. H., Wu, T. D., Misra, A., Nigro, J. M., Colman, H., Soroceanu, L., et al. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.02.019 · Cited by 3,143
Hypoxia-inducible factors and the response to hypoxic stress
Majmundar, A. J., Wong, W. J., & Simon, M. C. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.09.022 · Cited by 2,380
Identification of a CpG Island Methylator Phenotype that Defines a Distinct Subgroup of Glioma
Noushmehr, H., Weisenberger, D. J., Diefes, K., Phillips, H. S., Pujara, K., Berman, B. P., Pan, F., Pelloski, C. E., Sulman, E. P., Bhat, K. P., et al. (2010) · Cancer Cell · doi:10.1016/j.ccr.2010.03.017 · Cited by 2,337
Oxygen sensing by HIF hydroxylases
Schofield, C. J., & Ratcliffe, P. J. (2004) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1366 · Cited by 2,068
Regulation of Mammalian O 2 Homeostasis by Hypoxia-Inducible Factor 1
Semenza, G. L. (1999) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.15.1.551 · Cited by 1,914
Venkatachalam, K., & Montell, C. (2007) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.75.103004.142819 · Cited by 1,909
The EMT-activator ZEB1 promotes tumorigenicity by repressing stemness-inhibiting microRNAs
Wellner, U., Schubert, J., Burk, U. C., Schmalhofer, O., Zhu, F., Sonntag, A., Waldvogel, B., Vannier, C., Darling, D., Hausen, A. Z., et al. (2009) · Nature Cell Biology · doi:10.1038/ncb1998 · Cited by 1,699
HIF1α and HIF2α: sibling rivalry in hypoxic tumour growth and progression
Keith, B., Johnson, R. S., & Simon, M. C. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3183 · Cited by 1,693 · cited 3×
“HIFs are heterodimeric complexes constituted by O2-regulated α subunits (HIF-1α, EPAS1/HIF-2α, or HIF-3α) and a constitutively expressed β subunit, HIF-1β, also known as an aryl hydrocarbon receptor nuclear translocator (ARNT) [34,35].”
BackgroundPrinciples and mechanisms of vessel normalization for cancer and other angiogenic diseases
Carmeliet, P., & Jain, R. K. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3455 · Cited by 1,675
Lando, D., Peet, D. J., Gorman, J. J., Whelan, D. A., Whitelaw, M. L., & Bruick, R. K. (2002) · Genes & Development · doi:10.1101/gad.991402 · Cited by 1,550 · cited 1×
“Factor-inhibiting HIF (FIH) is also an O2 regulated hydroxylase that blocks the interaction between HIF-α and the transcriptional activators, p300/CBP, through asparagine hydroxylation of HIFα, attenuating HIF transactivation activity [48,49].”
BackgroundHypoxia-inducible factors: mediators of cancer progression and targets for cancer therapy
Semenza, G. L. (2012) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2012.01.005 · Cited by 1,514
(2000) · PubMed · Cited by 1,445
Jain, R. K., di Tomaso, E., Duda, D. G., Loeffler, J. S., Sorensen, A. G., & Batchelor, T. T. (2007) · Nature Reviews Neuroscience · doi:10.1038/nrn2175 · Cited by 1,405
Mahon, P. C., Hirota, K., & Semenza, G. L. (2001) · Genes & Development · doi:10.1101/gad.924501 · Cited by 1,385
Direct regulation of TWIST by HIF-1α promotes metastasis
Yang, M.-H., Wu, M.-Z., Chiou, S.-H., Chen, P.-M., Chang, S.-Y., Liu, C.-J., Teng, S.-C., & Wu, K.-J. (2008) · Nature Cell Biology · doi:10.1038/ncb1691 · Cited by 1,345
Regulation of tumor angiogenesis by p53-induced degradation of hypoxia-inducible factor 1alpha.
Ravi, R. K., Mookerjee, B., Bhujwalla, Z. M., Sutter, T. R., Artemov, D., Zeng, Q., Dillehay, L. E., Madan, A., Semenza, G. L., & Bedi, A. (2000) · PubMed · Cited by 1,230
Huang, L. E., Arany, Z., Livingston, D. M., & Bunn, H. F. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.50.32253 · Cited by 1,190
CXCR4: a key receptor in the crosstalk between tumor cells and their microenvironment
Burger, J. A., & Kipps, T. J. (2006) · Blood · doi:10.1182/blood-2005-08-3182 · Cited by 1,170
Kinetics of vascular normalization by VEGFR2 blockade governs brain tumor response to radiation
Winkler, F., Kozin, S. V., Tong, R. T., Chae, S.-S., Booth, M. F., Garkavtsev, I., Xu, L., Hicklin, D. J., Fukumura, D., di Tomaso, E., et al. (2004) · Cancer Cell · doi:10.1016/j.ccr.2004.10.011 · Cited by 1,170
Maira, S.-M., Stauffer, F., Brueggen, J., Furet, P., Schnell, C., Fritsch, C., Brachmann, S., Chène, P., De Pover, A., Schoemaker, K., et al. (2008) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-08-0017 · Cited by 1,134
Dose-Dense Temozolomide for Newly Diagnosed Glioblastoma: A Randomized Phase III Clinical Trial
Gilbert, M. R., Wang, M., Aldape, K. D., Stupp, R., Hegi, M. E., Jaeckle, K. A., Armstrong, T. S., Wefel, J. S., Won, M., Blumenthal, D. T., et al. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2013.49.6968 · Cited by 1,063
Stupp, R., Hegi, M. E., Gorlia, T., Erridge, S. C., Perry, J., Hong, Y.-K., Aldape, K. D., Lhermitte, B., Pietsch, T., Grujicic, D., et al. (2014) · The Lancet Oncology · doi:10.1016/s1470-2045(14)70379-1 · Cited by 1,052
Cockman, M. E., Masson, N., Mole, D. R., Jaakkola, P., Chang, G.-W., Clifford, S. C., Maher, E. R., Pugh, C. W., Ratcliffe, P. J., & Maxwell, P. H. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m002740200 · Cited by 1,050
Gao, X., Wu, G., Gu, X., Fu, L., & Mei, C. (2013) · Kidney and Blood Pressure Research · doi:10.1159/000355743 · Cited by 1,035
Timmerman, L. A., Grego-Bessa, J., Raya, A., Bertrán, E., Pérez-Pomares, J. M., Díez, J., Aranda, S., Palomo, S., McCormick, F., Izpisúa-Belmonte, J. C., et al. (2004) · Genes & Development · doi:10.1101/gad.276304 · Cited by 985
Regulation of tumor angiogenesis by p53-induced degradation of hypoxia-inducible factor 1α
Ravi, R., Mookerjee, B., Bhujwalla, Z. M., Sutter, C. H., Artemov, D., Zeng, Q., Dillehay, L. E., Madan, A., Semenza, G. L., & Bedi, A. (2000) · Genes & Development · doi:10.1101/gad.14.1.34 · Cited by 967
Zhou, W., Ke, S. Q., Huang, Z., Flavahan, W., Fang, X., Paul, J., Wu, L., Sloan, A. E., McLendon, R. E., Li, X., et al. (2015) · Nature Cell Biology · doi:10.1038/ncb3090 · Cited by 940
The Biology and Clinical Relevance of the PTEN Tumor Suppressor Pathway
Sansal, I., & Sellers, W. R. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.02.141 · Cited by 921
Ulrich, T. A., de Juan Pardo, E. M., & Kumar, S. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-4859 · Cited by 901
Hsp90 Molecular Chaperone Inhibitors: Are We There Yet?
Neckers, L., & Workman, P. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-1000 · Cited by 891
Kioi, M., Vogel, H., Schultz, G., Hoffman, R. M., Harsh, G. R., & Brown, J. M. (2010) · Journal of Clinical Investigation · doi:10.1172/jci40283 · Cited by 773
Hypoxia and the hypoxia-inducible-factor pathway in glioma growth and angiogenesis
Kaur, B., Khwaja, F. W., Severson, E. A., Matheny, S. L., Brat, D. J., & Van Meir, E. G. (2005) · Neuro-Oncology · doi:10.1215/s1152851704001115 · Cited by 725
Galanis, E., Buckner, J. C., Maurer, M. J., Kreisberg, J. I., Ballman, K., Boni, J., Peralba, J. M., Jenkins, R. B., Dakhil, S. R., Morton, R. F., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.23.622 · Cited by 694
Diversity and frequency of epidermal growth factor receptor mutations in human glioblastomas.
Frederick, L. A., Wang, X. Y., Eley, G. D., & James, C. D. (2000) · PubMed · Cited by 661
Zagzag, D., Zhong, H., Scalzitti, J. M., Laughner, E., Simons, J. W., & Semenza, G. L. (2000) · Cancer · doi:10.1002/1097-0142(20000601)88:11<2606::aid-cncr25>3.0.co;2-w · Cited by 604
Ekstrand, A. J., Sugawa, N., James, C. D., & Collins, V. P. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.10.4309 · Cited by 602
Sugawa, N., Ekstrand, A. J., James, C. D., & Collins, V. P. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.21.8602 · Cited by 594
Cloughesy, T. F., Yoshimoto, K., Nghiemphu, P., Brown, K., Dang, J., Zhu, S., Hsueh, T., Chen, Y., Wang, W., Youngkin, D., et al. (2008) · PLoS Medicine · doi:10.1371/journal.pmed.0050008 · Cited by 593
Rong, Y., Durden, D. L., Van Meir, E. G., & Brat, D. J. (2006) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-200606000-00001 · Cited by 567
Holland, E. C., Hively, W. P., DePinho, R. A., & Varmus, H. E. (1998) · Genes & Development · doi:10.1101/gad.12.23.3675 · Cited by 556
Inhibition of T-tropic HIV Strains by Selective Antagonization of the Chemokine Receptor CXCR4
Schols, D., Struyf, S., Damme, J. V., Esté, J. A., Henson, G., & Clercq, E. D. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.8.1383 · Cited by 554
Miao, H., Burnett, E., Kinch, M., Simon, E., & Wang, B. (2000) · Nature Cell Biology · doi:10.1038/35000008 · Cited by 548
Miao, H., Li, D.-Q., Mukherjee, A., Guo, H., Petty, A., Cutter, J., Basilion, J. P., Sedor, J., Wu, J., Danielpour, D., et al. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.04.009 · Cited by 533
Halama, N., Zoernig, I., Berthel, A., Kahlert, C., Klupp, F., Suarez-Carmona, M., Suetterlin, T., Brand, K., Krauss, J., Lasitschka, F., et al. (2016) · Cancer Cell · doi:10.1016/j.ccell.2016.03.005 · Cited by 495
Brat, D. J., Castellano-Sanchez, A. A., Hunter, S. B., Pecot, M., Cohen, C., Hammond, E. H., Devi, S. N., Kaur, B., & Van Meir, E. G. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-2073 · Cited by 485
Reardon, D. A., Fink, K. L., Mikkelsen, T., Cloughesy, T. F., O'Neill, A., Plotkin, S., Glantz, M., Ravin, P., Raizer, J. J., Rich, K. M., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2008.16.7510 · Cited by 481
Yuan, F., Salehi, H. A., Boucher, Y., Vasthare, U. S., Tuma, R. F., & Jain, R. K. (1994) · PubMed · Cited by 463
Mitochondrial complex III regulates hypoxic activation of HIF
Klimova, T., & Chandel, N. S. (2008) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4402307 · Cited by 433
Anticancer Targets in the Glycolytic Metabolism of Tumors: A Comprehensive Review
Porporato, P. E., Dhup, S., Dadhich, R. K., Copetti, T., & Sonveaux, P. (2011) · Frontiers in Pharmacology · doi:10.3389/fphar.2011.00049 · Cited by 425
Snail2 is an Essential Mediator of Twist1-Induced Epithelial Mesenchymal Transition and Metastasis
Casas, E., Kim, J., Bendesky, A., Ohno-Machado, L., Wolfe, C. J., & Yang, J. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-2330 · Cited by 423
Kallio, P. J., Pongratz, I., Gradin, K., McGuire, J., & Poellinger, L. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.11.5667 · Cited by 415
Multiple connections link FAK to cell motility and invasion
Schlaepfer, D. D., & Mitra, S. K. (2004) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2003.12.002 · Cited by 415
Identification of PLOD2 as Telopeptide Lysyl Hydroxylase, an Important Enzyme in Fibrosis
van der Slot, A. J., Zuurmond, A.-M., Bardoel, A. F. J., Wijmenga, C., Pruijs, H. E. H., Sillence, D. O., Brinckmann, J., Abraham, D. J., Black, C. M., Verzijl, N., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m307380200 · Cited by 409
Zagzag, D., Lukyanov, Y., Lan, L., Ali, M. A., Esencay, M., Mendez, O., Yee, H., Voura, E. B., & Newcomb, E. W. (2006) · Laboratory Investigation · doi:10.1038/labinvest.3700482 · Cited by 396
The ZEB1 pathway links glioblastoma initiation, invasion and chemoresistance
Siebzehnrubl, F. A., Silver, D. J., Tugertimur, B., Deleyrolle, L. P., Siebzehnrubl, D., Sarkisian, M. R., Devers, K. G., Yachnis, A. T., Kupper, M. D., Neal, D., et al. (2013) · EMBO Molecular Medicine · doi:10.1002/emmm.201302827 · Cited by 381
Bar, E. E., Lin, A., Mahairaki, V., Matsui, W., & Eberhart, C. G. (2010) · The American Journal of Pathology · doi:10.2353/ajpath.2010.091021 · Cited by 373
Rempel, S. A., Dudas, S., Ge, S., & Gutierrez, J. A. (2000) · PubMed · Cited by 364
Multilayer control of the EMT master regulators
Zheng, H., & Kang, Y. (2014) · Oncogene · doi:10.1038/onc.2013.128 · Cited by 346
Brat, D. J., & Van Meir, E. G. (2004) · Laboratory Investigation · doi:10.1038/labinvest.3700070 · Cited by 330
BMI1 Sustains Human Glioblastoma Multiforme Stem Cell Renewal
Abdouh, M., Facchino, S., Chatoo, W., Balasingam, V., Ferreira, J., & Bernier, G. (2009) · Journal of Neuroscience · doi:10.1523/jneurosci.0968-09.2009 · Cited by 326
Inhibitors of the heat shock response: Biology and pharmacology
Powers, M. V., & Workman, P. (2007) · FEBS Letters · doi:10.1016/j.febslet.2007.05.040 · Cited by 320
Hypoxia-inducible Factor and Its Biomedical Relevance
Huang, L. E., & Bunn, H. F. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.r200030200 · Cited by 315
Biochemical Characterization of CA IX, One of the Most Active Carbonic Anhydrase Isozymes
Hilvo, M., Baranauskiene, L., Salzano, A. M., Scaloni, A., Matulis, D., Innocenti, A., Scozzafava, A., Monti, S. M., Di Fiore, A., De Simone, G., et al. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m800938200 · Cited by 307
Gliomas and the vascular fragility of the blood brain barrier
Dubois, L. G., Campanati, L., Righy, C., D’Andrea-Meira, I., Spohr, T. C. L. D. S. E., Porto-Carreiro, I., Pereira, C. M., Balça-Silva, J., Kahn, S. A., DosSantos, M. F., et al. (2014) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2014.00418 · Cited by 303
The NF1 somatic mutational landscape in sporadic human cancers
Philpott, C., Tovell, H., Frayling, I. M., Cooper, D. N., & Upadhyaya, M. (2017) · Human Genomics · doi:10.1186/s40246-017-0109-3 · Cited by 303
Joseph, J. V., Conroy, S., Pavlov, K., Sontakke, P., Tomar, T., Eggens-Meijer, E., Balasubramaniyan, V., Wagemakers, M., den Dunnen, W. F. A., & Kruyt, F. A. E. (2015) · Cancer Letters · doi:10.1016/j.canlet.2015.01.010 · Cited by 302
Felsberg, J., Thon, N., Eigenbrod, S., Hentschel, B., Sabel, M. C., Westphal, M., Schackert, G., Kreth, F. W., Pietsch, T., Löffler, M., et al. (2011) · International Journal of Cancer · doi:10.1002/ijc.26083 · Cited by 297
TWIST activation by hypoxia inducible factor-1 (HIF-1): Implications in metastasis and development
Yang, M.-H., & Wu, K.-J. (2008) · Cell Cycle · doi:10.4161/cc.7.14.6324 · Cited by 295
Phase I and Correlative Biology Study of Cilengitide in Patients With Recurrent Malignant Glioma
Nabors, L. B., Mikkelsen, T., Rosenfeld, S. S., Hochberg, F., Akella, N. S., Fisher, J. D., Cloud, G. A., Zhang, Y., Carson, K., Wittemer, S. M., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.06.6514 · Cited by 290
EphA2 as a Novel Molecular Marker and Target in Glioblastoma Multiforme
Wykosky, J., Gibo, D. M., Stanton, C., & Debinski, W. (2005) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-05-0056 · Cited by 290
TWIST1 promotes invasion through mesenchymal change in human glioblastoma
Mikheeva, S. A., Mikheev, A. M., Petit, A., Beyer, R., Oxford, R. G., Khorasani, L., Maxwell, J.-P., Glackin, C. A., Wakimoto, H., González-Herrero, I., et al. (2010) · Molecular Cancer · doi:10.1186/1476-4598-9-194 · Cited by 289
Vessel Tortuosity and Brain Tumor Malignancy
Bullitt, E., Zeng, D., Gerig, G., Aylward, S., Joshi, S., Smith, J. K., Lin, W., & Ewend, M. G. (2005) · Academic Radiology · doi:10.1016/j.acra.2005.05.027 · Cited by 285
Ebert, B. L., & Bunn, H. F. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.7.4089 · Cited by 282
Aldape, K. D., Ballman, K., Furth, A., Buckner, J. C., Giannini, C., Burger, P. C., Scheithauer, B. W., Jenkins, R. B., & James, C. D. (2004) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/63.7.700 · Cited by 278
Hypoxia-Dependent Modification of Collagen Networks Promotes Sarcoma Metastasis
Eisinger-Mathason, T. S. K., Zhang, M., Qiu, Q., Skuli, N., Nakazawa, M. S., Karakasheva, T., Mucaj, V., Shay, J. E. S., Stangenberg, L., Sadri, N., et al. (2013) · Cancer Discovery · doi:10.1158/2159-8290.cd-13-0118 · Cited by 277
Hypoxia-inducible factor 3 biology: complexities and emerging themes
Duan, C. (2016) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00315.2015 · Cited by 269
HSP27, 70 and 90, anti-apoptotic proteins, in clinical cancer therapy
WANG, X., CHEN, M., ZHOU, J., & ZHANG, X. (2014) · International Journal of Oncology · doi:10.3892/ijo.2014.2399 · Cited by 269
Mao, H., LeBrun, D. G., Yang, J., Zhu, V. F., & Li, M. (2012) · Cancer Investigation · doi:10.3109/07357907.2011.630050 · Cited by 266
Gerlach, L. O., Skerlj, R. T., Bridger, G. J., & Schwartz, T. W. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m010429200 · Cited by 260
A conditional feedback loop regulates Ras activity through EphA2
Macrae, M., Neve, R. M., Rodriguez-Viciana, P., Haqq, C., Yeh, J., Chen, C., Gray, J. W., & McCormick, F. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.07.005 · Cited by 260
Flügel, D., Görlach, A., Michiels, C., & Kietzmann, T. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.00015-07 · Cited by 258
Angiogenesis and prostate cancer: identification of a molecular progression switch.
Huss, W. J., Hanrahan, C. F., Barrios, R. J., Simons, J. W., & Greenberg, N. M. (2001) · PubMed · Cited by 253
Liu, T.-J., Koul, D., LaFortune, T., Tiao, N., Shen, R. J., Maira, S.-M., Garcia-Echevrria, C., & Yung, W. K. A. (2009) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-09-0160 · Cited by 253
PTEN and Hypoxia Regulate Tissue Factor Expression and Plasma Coagulation by Glioblastoma
Rong, Y., Post, D. E., Pieper, R. O., Durden, D. L., Van Meir, E. G., & Brat, D. J. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-3376 · Cited by 239
Zhang, P., Yao, Q., Lu, L., Li, Y., Chen, P.-J., & Duan, C. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.02.011 · Cited by 231
Signaling of the Tissue Factor Coagulation Pathway in Angiogenesis and Cancer
Belting, M., Ahamed, J., & Ruf, W. (2005) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000171155.05809.bf · Cited by 221
A Twist in fate: evolutionary comparison of Twist structure and function
Castanon, I., & Baylies, M. K. (2002) · Gene · doi:10.1016/s0378-1119(01)00893-9 · Cited by 217
Bennin, D. A., Don, A. S. A., Brake, T., McKenzie, J. L., Rosenbaum, H., Ortiz, L., DePaoli-Roach, A. A., & Horne, M. C. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m111693200 · Cited by 209
CXCR4 expression mediates glioma cell invasiveness
Ehtesham, M., Winston, J. A., Kabos, P., & Thompson, R. C. (2006) · Oncogene · doi:10.1038/sj.onc.1209302 · Cited by 198
Receptor Channel TRPC6 Is a Key Mediator of Notch-Driven Glioblastoma Growth and Invasiveness
Chigurupati, S., Venkataraman, R., Barrera, D., Naganathan, A., Madan, M., Paul, L., Pattisapu, J. V., Kyriazis, G. A., Sugaya, K., Bushnev, S., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-2654 · Cited by 198
Méndez, O., Zavadil, J., Esencay, M., Lukyanov, Y., Santovasi, D., Wang, S.-C., Newcomb, E. W., & Zagzag, D. (2010) · Molecular Cancer · doi:10.1186/1476-4598-9-133 · Cited by 193
Expression of tissue factor correlates with grade of malignancy in human glioma
Hamada, K., Kuratsu, J.-I., Saitoh, Y., Takeshima, H., Nishi, T., & Ushio, Y. (1996) · Cancer · doi:10.1002/(sici)1097-0142(19960501)77:9<1877::aid-cncr18>3.0.co;2-x · Cited by 184
Activation of the repulsive receptor Roundabout inhibits N-cadherin-mediated cell adhesion
Rhee, J., Mahfooz, N. S., Arregui, C., Lilien, J., Balsamo, J., & VanBerkum, M. F. A. (2002) · Nature Cell Biology · doi:10.1038/ncb858 · Cited by 183
Hallmarks of glioblastoma: a systematic review
Nørøxe, D. S., Poulsen, H. S., & Lassen, U. (2016) · ESMO Open · doi:10.1136/esmoopen-2016-000144 · Cited by 183
Yang, L., Lin, C., Wang, L., Guo, H., & Wang, X. (2012) · Experimental Cell Research · doi:10.1016/j.yexcr.2012.07.017 · Cited by 178
Glomeruloid Microvascular Proliferation Orchestrated by VPF/VEGF
Brat, D. J., & Meir, E. G. V. (2001) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64025-4 · Cited by 177
TWIST is Expressed in Human Gliomas, Promotes Invasion
Elias, M. C., Tozer, K. R., Silber, J. R., Mikheeva, S., Deng, M., Morrison, R. S., Manning, T. C., Silbergeld, D. L., Glackin, C. A., Reh, T. A., et al. (2005) · Neoplasia · doi:10.1593/neo.04352 · Cited by 176
Maraviroc: A CCR5-receptor antagonist for the treatment of HIV-1 infection
Lieberman-Blum, S. S., Fung, H. B., & Bandres, J. C. (2008) · Clinical Therapeutics · doi:10.1016/s0149-2918(08)80048-3 · Cited by 176
Koul, D., Fu, J., Shen, R., LaFortune, T. A., Wang, S., Tiao, N., Kim, Y.-W., Liu, J.-L., Ramnarian, D., Yuan, Y., et al. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-1558 · Cited by 171
TWISTing an embryonic transcription factor into an oncoprotein
Ansieau, S., Morel, A.-P., Hinkal, G., Bastid, J., & Puisieux, A. (2010) · Oncogene · doi:10.1038/onc.2010.92 · Cited by 167
Serres, E., Debarbieux, F., Stanchi, F., Maggiorella, L., Grall, D., Turchi, L., Burel-Vandenbos, F., Figarella-Branger, D., Virolle, T., Rougon, G., et al. (2014) · Oncogene · doi:10.1038/onc.2013.305 · Cited by 158
Soroceanu, L., Murase, R., Limbad, C., Singer, E. A., Allison, J., Adrados, I., Kawamura, R., Pakdel, A., Fukuyo, Y., Nguyen, D., et al. (2012) · Cancer Research · doi:10.1158/0008-5472.can-12-1943 · Cited by 158
Malden, L. T., Novak, U., Kaye, A. H., & Burgess, A. W. (1988) · PubMed · Cited by 156
SNAI2/Slug promotes growth and invasion in human gliomas
Yang, H. W., Menon, L. G., Black, P. M., Carroll, R. S., & Johnson, M. D. (2010) · BMC Cancer · doi:10.1186/1471-2407-10-301 · Cited by 154
Current clinical development of PI3K pathway inhibitors in glioblastoma
Wen, P. Y., Lee, E. Q., Reardon, D. A., Ligon, K. L., & Yung, W. K. A. (2012) · Neuro-Oncology · doi:10.1093/neuonc/nos117 · Cited by 144
MacDonald, T. J., Stewart, C. F., Koçak, M., Goldman, S., Ellenbogen, R. G., Phillips∥, P. C., Lafond, D. A., Poussaint, T. Y., Kieran, M. W., Boyett, J. M., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.14.1812 · Cited by 144
TWIST1-WDR5- Hottip Regulates Hoxa9 Chromatin to Facilitate Prostate Cancer Metastasis
Malek, R. A., Gajula, R. P., Williams, R. D., Nghiem, B., Simons, B. W., Nugent, K. M., Wang, H., Taparra, K., Lemtiri-Chlieh, G., Yoon, A. R., et al. (2017) · Cancer Research · doi:10.1158/0008-5472.can-16-2797 · Cited by 144
αvβ3/αvβ5 Integrins-FAK-RhoB: A Novel Pathway for Hypoxia Regulation in Glioblastoma
Skuli, N., Monferran, S., Delmas, C., Favre, G., Bonnet, J., Toulas, C., & Moyal, E. C. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-2158 · Cited by 141
Srinivas, V., Zhang, L.-P., Zhu, X.-H., & Caro, J. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.0878 · Cited by 140
Gopal, U., Bohonowych, J. E. S., Tomé, C. M. L., Liu, A., Garrett-Mayer, E. S., Wang, B., & Isaacs, J. S. (2011) · PLoS ONE · doi:10.1371/journal.pone.0017649 · Cited by 139
Stiff Collagen Matrices Increase Tumorigenic Prolactin Signaling in Breast Cancer Cells
Barcus, C. E., Keely, P. J., Eliceiri, K. W., & Schuler, L. A. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.447631 · Cited by 139
Function of carbonic anhydrase IX in glioblastoma multiforme
Proescholdt, M. A., Merrill, M. J., Stoerr, E.-M., Lohmeier, A., Pohl, F., & Brawanski, A. T. (2012) · Neuro-Oncology · doi:10.1093/neuonc/nos216 · Cited by 139
Tissue Factor and PAR2 Signaling in the Tumor Microenvironment
Schaffner, F., & Ruf, W. (2009) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.108.177428 · Cited by 139
Vascular morphology and angiogenesis in glial tumors
Plate, K. H., & Mennel, H. D. (1995) · Experimental and Toxicologic Pathology · doi:10.1016/s0940-2993(11)80292-7 · Cited by 131
Antibody–drug conjugates in glioblastoma therapy: the right drugs to the right cells
Gan, H. K., van den Bent, M. J., Lassman, A. B., Reardon, D. A., & Scott, A. M. (2017) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2017.95 · Cited by 126
CCR5 Antagonists: Host-Targeted Antivirals for the Treatment of HIV Infection
Westby, M., & van der Ryst, E. (2005) · Antiviral chemistry & chemotherapy · doi:10.1177/095632020501600601 · Cited by 125
SDF-1 and CXCR4 are up-regulated by VEGF and contribute to glioma cell invasion
Hong, X., Jiang, F., Kalkanis, S. N., Zhang, Z. G., Zhang, X.-P., deCarvalho, A. C., Katakowski, M., Bobbitt, K. R., Mikkelsen, T., & Chopp, M. (2005) · Cancer Letters · doi:10.1016/j.canlet.2005.05.011 · Cited by 124
Jensen, R. L., Mumert, M. L., Gillespie, D. L., Kinney, A. Y., Schabel, M. C., & Salzman, K. L. (2013) · Neuro-Oncology · doi:10.1093/neuonc/not148 · Cited by 115
Halvorsen, E. C., Hamilton, M. J., Young, A., Wadsworth, B. J., LePard, N. E., Lee, H. N., Firmino, N. S., Collier, J. L., & Bennewith, K. L. (2016) · OncoImmunology · doi:10.1080/2162402x.2016.1150398 · Cited by 115
LOX Expression and Functional Analysis in Astrocytomas and Impact of IDH1 Mutation
da Silva, R., Uno, M., Marie, S. K. N., & Oba‐Shinjo, S. M. (2015) · PLoS ONE · doi:10.1371/journal.pone.0119781 · Cited by 113
Angiogenesis and expression of PDGF ‐ C , VEGF , CD 105 and HIF ‐1α in human glioblastoma
Clara, C., Marie, S. K. N., Almeida, J. R. W., Wakamatsu, A., Oba‐Shinjo, S. M., Uno, M., Neville, M. A., & Rosemberg, S. (2014) · Neuropathology · doi:10.1111/neup.12111 · Cited by 112
The potential to target CCL5/CCR5 in breast cancer
Velasco-Velázquez, M. A., Xolalpa, W., & Pestell, R. G. (2014) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2014.949238 · Cited by 110
The Tumorigenic Roles of the Cellular REDOX Regulatory Systems
Castaldo, S. A., Freitas, J. R., Conchinha, N. V., & Madureira, P. A. (2015) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2016/8413032 · Cited by 109
Self-citationWang, L., Fokas, E., Bieker, M., Rose, F., Rexin, P., Zhu, Y., Pagenstecher, A., Engenhart‐Cabillic, R., & An, H. (2008) · Oncology Reports · doi:10.3892/or.19.1.151 · Cited by 109
Du, H., Pang, M., Hou, X., Yuan, S., & Sun, L. (2017) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2017.04.023 · Cited by 106
Role of tenascins in the ECM of gliomas
Brösicke, N., & Faissner, A. (2015) · Cell Adhesion & Migration · doi:10.1080/19336918.2014.1000071 · Cited by 105
Mercurio, L., Ajmone‐Cat, M. A., Cecchetti, S., Ricci, A. L., Bozzuto, G., Molinari, A., Manni, I., Pollo, B., Scala, S., Carpinelli, G., et al. (2016) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-016-0326-y · Cited by 105
Gene expressions of TRP channels in glioblastoma multiforme and relation with survival
Alptekin, M., Eroğlu, S., Tutar, E., Şencan, S., GEYİK, M., Ulaşlı, M., Demiryürek, A. T., & Camcı, C. (2015) · Tumor Biology · doi:10.1007/s13277-015-3577-x · Cited by 104
Guruvayoorappan, C., & Kuttan, G. (2008) · Immunopharmacology and Immunotoxicology · doi:10.1080/08923970802278276 · Cited by 104
Rong, Y., Hu, F., Huang, R.-P., Mackman, N., Horowitz, J. M., Jensen, R. L., Durden, D. L., Meir, E. G. V., & Brat, D. J. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-0346 · Cited by 102
Hypoxia-Mediated Mechanisms Associated with Antiangiogenic Treatment Resistance in Glioblastomas
Mahase, S. S., Rattenni, R. N., Wesseling, P., Leenders, W. P. J., Baldotto, C. S. D. R., Jain, R., & Zagzag, D. (2017) · American Journal Of Pathology · doi:10.1016/j.ajpath.2017.01.010 · Cited by 98
Genetic and Biologic Progression in Astrocytomas and Their Relation to Angiogenic Dysregulation
Brat, D. J., Castellano-Sanchez, A. A., Kaur, B., & Meir, E. G. V. (2002) · Advances in Anatomic Pathology · doi:10.1097/00125480-200201000-00004 · Cited by 96
Lin, F., de Gooijer, M. C., Hanekamp, D., Chandrasekaran, G., Buil, L. C. M., Thota, N., Sparidans, R. W., Beijnen, J. H., Würdinger, T., & van Tellingen, O. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-16-1276 · Cited by 90
Clarke, K., Smith, K. J., Gullick, W., & Harris, A. L. (2001) · British Journal of Cancer · doi:10.1054/bjoc.2001.1805 · Cited by 89
Said, H. M., Hagemann, C., Staab, A., Stojic, J., Kühnel, S., Vince, G. H., Flentje, M. P., Roosen, K., & Vordermark, D. (2007) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2007.05.003 · Cited by 86
Wang, L., Fokas, E., Juricko, J., You, A. B., Rose, F., Pagenstecher, A., Engenhart‐Cabillic, R., & An, H. (2008) · BMC Cancer · doi:10.1186/1471-2407-8-79 · Cited by 85
Guruvayoorappan, C., & Kuttan, G. (2007) · Integrative Cancer Therapies · doi:10.1177/1534735407305978 · Cited by 84
Don, A. S. A., Dallapiazza, R. F., Bennin, D. A., Brake, T., Cowan, C. E., & Horne, M. C. (2006) · Experimental Cell Research · doi:10.1016/j.yexcr.2006.09.023 · Cited by 77
Role and Therapeutic Targeting of the HGF/MET Pathway in Glioblastoma
Cruickshanks, N. A., Zhang, Y., Yuan, F., Pahuski, M., Gibert, M. K., & Abounader, R. (2017) · Cancers · doi:10.3390/cancers9070087 · Cited by 74
Targeting EGFRvIII for glioblastoma multiforme
Yang, J. D., Yan, J., & Liu, B. (2017) · Cancer Letters · doi:10.1016/j.canlet.2017.06.024 · Cited by 69
Hypoxia and macrophages promote glioblastoma invasion by the CCL4-CCR5 axis
Wang, Y., Liu, T., Yang, N., Xu, S., Li, X., & Wang, D. (2016) · Oncology Reports · doi:10.3892/or.2016.5171 · Cited by 68
RBPJ maintains brain tumor–initiating cells through CDK9-mediated transcriptional elongation
Xie, Q., Wu, Q., Kim, L. J. Y., Miller, T. E., Liau, B. B., Mack, S. C., Yang, K., Factor, D. C., Fang, X., Huang, Z., et al. (2016) · Journal of Clinical Investigation · doi:10.1172/jci86114 · Cited by 67
ZEB1 Promotes Invasion in Human Fetal Neural Stem Cells and Hypoxic Glioma Neurospheres
Kahlert, U. D., Suwala, A. K., Raabe, E. H., Siebzehnrübl, F. A., Suarez, M. J., Orr, B. A., Bar, E. E., Maciaczyk, J., & Eberhart, C. G. (2014) · Brain Pathology · doi:10.1111/bpa.12240 · Cited by 66
Gessler, F. A., Voss, V., Duetzmann, S., Seifert, V., Gerlach, R., & Kögel, D. (2009) · Neuroscience · doi:10.1016/j.neuroscience.2009.11.049 · Cited by 66
Kaur, H., Phillips‐Mason, P. J., Burden‐Gulley, S. M., Kerstetter-Fogle, A. E., Basilion, J. P., Sloan, A. E., & Brady‐Kalnay, S. M. (2012) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-11-0457 · Cited by 63
Tanabe, Y., Sasaki, S., Mukaida, N., & Baba, T. (2016) · Oncotarget · doi:10.18632/oncotarget.10227 · Cited by 63
The Aurora-A–Twist1 axis promotes highly aggressive phenotypes in pancreatic carcinoma
Wang, J., Nikhil, K., Viccaro, K., Chang, L., Jacobsen, M. H., Sandusky, G. E., & Shah, K. (2017) · Journal of Cell Science · doi:10.1242/jcs.196790 · Cited by 63
Marotta, D. E., Karar, J., Jenkins, W. T., Kumanova, M., Jenkins, K. W., Tobias, J. W., Baldwin, D. A., Hatzigeorgiou, A. G., Alexiou, P., Evans, S. M., et al. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-3061 · Cited by 62
Liu, Z., Han, L., Dong, Y., Tan, Y., Li, Y., Zhao, M., Xie, H., Ju, H., Wang, H., Zhao, Y., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.6730 · Cited by 62
Ragel, B. T., Couldwell, W. T., Gillespie, D. L., & Jensen, R. L. (2007) · Neurosurgical Review · doi:10.1007/s10143-007-0070-z · Cited by 54
Annamalai, B., Liu, X., Gopal, U., & Isaacs, J. S. (2009) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-08-0582 · Cited by 51
Burden‐Gulley, S. M., Qutaish, M. Q., Sullivant, K. E., et al. (2011) · Cancer Research · doi:10.1158/0008-5472.can-11-1553 · Cited by 51
MacDonald, T. J., Vézina, G., Stewart, C. F., Turner, D. C., Pierson, C. R., Chen, L., Pollack, I. F., Gajjar, A. J., & Kieran, M. W. (2013) · Neuro-Oncology · doi:10.1093/neuonc/not058 · Cited by 50
Cells on the Move: A Dialogue Between Polarization and Motility
Mañes, S., Mira, E., Gómez‐Moutón, C., Lacalle, R. A., & Martínez‐A, C. (2000) · IUBMB Life · doi:10.1080/15216540050022386 · Cited by 48
Antitumor action of temozolomide, ritonavir and aprepitant against human glioma cells
Kast, R. E., Ramiro, S., Lladó, S., Toro, S., Coveñas, R., & Muñoz, M. (2015) · Journal of Neuro-Oncology · doi:10.1007/s11060-015-1996-6 · Cited by 48
FAT1 is a novel upstream regulator of HIF1α and invasion of high grade glioma
Madan, E., Dikshit, B., Gowda, S. H., Srivastava, C., Sarkar, C., Chattopadhyay, P., Sinha, S., & Chosdol, K. (2016) · International Journal of Cancer · doi:10.1002/ijc.30386 · Cited by 45
Hamsa, T. P., & Kuttan, G. (2011) · Phytotherapy Research · doi:10.1002/ptr.3586 · Cited by 43
Maciaczyk, D., Picard, D. J., Zhao, L., Koch, K., Herrera-Rios, D., Li, G., Marquardt, V., Pauck, D., Hörbelt, T., Zhang, W., et al. (2017) · British Journal of Cancer · doi:10.1038/bjc.2017.157 · Cited by 42
Inhibition of carbonic anhydrase IX in glioblastoma multiforme
Amiri, A., Le, P. U., Moquin, A., Machkalyan, G., Petrecca, K., Gillard, J. W., Yoganathan, N., & Maysinger, D. (2016) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2016.09.018 · Cited by 39
Hypoxia upregulates HIG2 expression and contributes to bevacizumab resistance in glioblastoma
Mao, X., Wang, C., Liu, D.-Y., Zhang, X., Wang, L., Yan, M., Zhang, W., Zhu, J., Li, Z., Mi, C., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.10029 · Cited by 38
Fujimura, A., Michiue, H., Cheng, Y., Uneda, A., Tani, Y., Nishiki, T., Ichikawa, T., Wei, F., Tomizawa, K., & Matsui, H. (2013) · Neoplasia · doi:10.1593/neo.131440 · Cited by 32
mRNA expression levels of hypoxia-induced and stem cell-associated genes in human glioblastoma
Bache, M., Rot, S., Keßler, J., Güttler, A., Wichmann, H., Greither, T., Wach, S., Taubert, H. W., Söling, A., Bilkenroth, U., et al. (2015) · Oncology Reports · doi:10.3892/or.2015.3932 · Cited by 32
Dactolisib (NVP-BEZ235) toxicity in murine brain tumour models
Netland, I. A., Førde, H. E., Sleire, L., Leiss, L. W., Rahman, M. A., Skeie, B. S., Gjerde, C. H., Enger, P. Ø., & Goplen, D. (2016) · BMC Cancer · doi:10.1186/s12885-016-2712-4 · Cited by 30
Twist predicts poor outcome of patients with astrocytic glioma
Nordfors, K., Haapasalo, J. A., Mäkelä, K., Granberg, K. J., Nykter, M., Korja, M., Paavonen, T., Haapasalo, H. K., & Soini, Y. (2015) · Journal of Clinical Pathology · doi:10.1136/jclinpath-2015-202868 · Cited by 27
Xu, Y., Zhang, L., Wei, Y., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.15581 · Cited by 24
Wang, M., Dignam, J. J., Won, M., Curran, W. J., Mehta, M. P., & Gilbert, M. R. (2015) · Neuro-Oncology · doi:10.1093/neuonc/nov009 · Cited by 21
Harter, P. N., Duetzmann, S., Drott, U., Zachskorn, C., Hattingen, E., Capper, D., Gessler, F. A., Senft, C., Seifert, V., Plate, K. H., et al. (2013) · Neuropathology · doi:10.1111/neup.12018 · Cited by 18
Said, H. M. (1994) · Oncology Reports · doi:10.3892/or_00000023 · Cited by 18
Geranylgeranyltransferase I regulates HIF-1α promoting glioblastoma cell migration and invasion
Zhou, X., Liu, Z., Shi, Q., Jiao, J., Bian, W., Song, X., Mo, J., Sang, B., Xu, Y., Qian, J., et al. (2013) · Journal of Neuro-Oncology · doi:10.1007/s11060-013-1081-y · Cited by 15
Role of proton pumps in tumorigenesis
Kobliakov, V. A. (2017) · Biochemistry (Moscow) · doi:10.1134/s0006297917040010 · Cited by 15
Cited by
Glioblastoma multiforme (GBM): An overview of current therapies and mechanisms of resistance
Wu, W., Klockow, J. L., Zhang, M., Lafortune, F., Chang, E., Jin, L., Wu, Y., & Daldrup-Link, H. E. (2021) · Pharmacological Research · doi:10.1016/j.phrs.2021.105780 · Cited by 805
Why develop photoactivated chemotherapy?
Bonnet, S. (2018) · Dalton Transactions · doi:10.1039/c8dt01585f · Cited by 297
Mechanisms of Resistance and Current Treatment Options for Glioblastoma Multiforme (GBM)
Yalamarty, S. S. K., Filipczak, N., Li, X., Subhan, M. A., Parveen, F., Ataide, J. A., Rajmalani, B. A., & Torchilin, V. P. (2023) · Cancers · doi:10.3390/cancers15072116 · Cited by 293
Serine-dependent redox homeostasis regulates glioblastoma cell survival
Engel, A. L., Lorenz, N. I., Klann, K., Münch, C., Depner, C., Steinbach, J. P., Ronellenfitsch, M. W., & Luger, A.-L. (2020) · British Journal of Cancer · doi:10.1038/s41416-020-0794-x · Cited by 85
Renfrow, J. J., Soike, M. H., West, J. L., Ramkissoon, S. H., Metheny-Barlow, L., Mott, R. T., Kittel, C. A., D’Agostino, R. B., Tatter, S. B., Laxton, A. W., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-72290-2 · Cited by 45
Metadata
- Authors
- Monteiro, A., Hill, R., Pilkington, G., & Madureira, P.
- Venue
- Cells
- Publisher
- MDPI AG
- Published
- 2017-11-22
- Volume
- 6
- Issue
- 4
- Pages
- 45
- ISSN
- 2073-4409 (ISSN-L)
- OpenAlex
- W2768515496
- Cited by
- 321
- References
- 183
- FWCI
- 10.17
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.